HQ: Los Angeles
310-966-1444 • brileyfin.com
B. Riley Financial measures its performance by how it shows up for its clients, collaborates to solve problems and provides end-to-end solutions to address clients’ needs in any economic environment.
B. Riley Financial approaches business from a relationship-first perspective, building upon personal and longstanding connections and deep business acumen to enable transformative growth for its clients across the middle market. B. Riley’s innovation is driven by continued advocacy of its clients and its ability to leverage the diverse
capabilities of its affiliated subsidiaries to enable its clients’ continued success. The company continues to invest to further enhance and diversify its platform and has made a series of strategic hires to meet growing client demand.
B. Riley’s acquisition of Farber earlier this year expanded its restructuring advisory capabilities and also established a new human capital consulting vertical with a dedicated team of professionals in Canada. B. Riley Farber’s interim management services facilitate the sourcing, retention and development of executive talent to support clients across North America for a variety of situations. The integration of Farber’s resources and capabilities extends B. Riley’s appraisal, valuation, litigation support and forensic services to clients, and provides a foundation to expand B. Riley’s corporate finance capabilities in Canada.
In addition to acquiring Farber, over the last year, B. Riley established a field exanimation practice, expanded its healthcare/life sciences and consumer investment banking teams and acquired ABTV, a restructuring advisory firm.
Against the backdrop of challenging markets, B. Riley is positioned to support its clients across a range of economic cycles. Clients can leverage multiple facets of B. Riley’s platform whether for capital raising, investment banking, strategic financial advisory, business restructuring, appraisal and valuation, or asset disposition. For example, B. Riley recently supported Harrow Health’s landmark acquisition of the exclusive commercial rights of five FDA-approved ophthalmic products.
“The ability to cater to our clients’ evolving needs with a holistic solution from a single platform differentiates B. Riley. We look forward to continuing to deliver value in the future.”